DRX DLY S&P Biotech Bull 3XETF
13F holders, Q2 2025 (June 30)5holders −1
0new positions
0sold out
$57.13avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding DRX DLY S&P Biotech Bull 3X in their 13F filings, down 1 from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were Parallel Advisors, LLC ($61K), Cornerstone Planning Group LLC ($2K) and Hollencrest Capital Management ($911).
- Company
- DRX DLY S&P Biotech Bull 3X
- Filed as
- DIREXION DAILY S&P BIOTECH BULL 3X SHARES (Q2 2025)
- CUSIP
- 25490K323
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 300 shares bought and 98 shares sold, net +202 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Parallel Advisors, LLC | 0.00% | Add +38.5% | 1,080 | $61K |
| Cornerstone Planning Group LLC | 0.00% | No change | 35 | $2K |
| Hollencrest Capital Management | 0.00% | No change | 16 | $911 |
| Pension & Wealth Management Advisors, Inc. | 0.00% | Reduce -40.0% | 15 | $854 |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -89.8% | 10 | $571 |
"% of holder's portfolio" is DRX DLY S&P BIOTECH BULL 3X's weight in each manager's 13F, not the share of DRX DLY S&P Biotech Bull 3X the manager owns.